MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+6.92%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.33B
AUM Growth
+$172M
(+15%)
Cap. Flow
+$110M
Cap. Flow
% of AUM
8.25%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,831
New
283
Increased
650
Reduced
474
Closed
292
Top Buys
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$15.6M |
| 2 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
+$12.7M |
| 3 |
CSX Corp
CSX
|
+$8.44M |
| 4 |
Humana
HUM
|
+$8.38M |
| 5 |
TJX Companies
TJX
|
+$7.77M |
Top Sells
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$17.2M |
| 2 |
Mastercard
MA
|
+$7.78M |
| 3 |
Elevance Health
ELV
|
+$7.28M |
| 4 |
Booking.com
BKNG
|
+$6.32M |
| 5 |
IBM
IBM
|
+$5.96M |
Sector Composition
| 1 | Technology | 17.07% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 11.38% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Ligand Pharmaceuticals
LGND
$3.24B
| $51K | ﹤0.01% |
298
+118
| +66% | +$20.2K |
|
777
Madison Square Garden
MSGS
$4.93B
| $51K | ﹤0.01% |
+229
| New | +$51K |
|
778
TechTarget
TTGT
$404M
| $51K | ﹤0.01% |
2,632
+50
| +2% | +$969 |
|
|
XENT
779
DELISTED
Intersect ENT, Inc
XENT
| $51K | ﹤0.01% |
1,779
-2,208
| -55% | -$63.3K |
|
|
HMSY
780
DELISTED
HMS Holdings Corp.
HMSY
| $51K | ﹤0.01% |
1,530
-1,732
| -53% | -$57.7K |
|
781
Assertio
ASRT
$77.5M
| $50K | ﹤0.01% |
2,165
+1,682
| +348% | +$38.8K |
|
782
Gold Resource Corp
GORO
$106M
| $50K | ﹤0.01% |
10,077
-1,424
| -12% | -$7.07K |
|
783
Hexcel
HXL
$4.93B
| $50K | ﹤0.01% |
741
-156
| -17% | -$10.5K |
|
784
SoundThinking
SSTI
$160M
| $50K | ﹤0.01% |
+841
| New | +$50K |
|
|
TPIC
785
DELISTED
TPI Composites
TPIC
| $50K | ﹤0.01% |
1,759
+715
| +68% | +$20.3K |
|
|
TRTX
786
TPG RE Finance Trust
TRTX
$744M
| $50K | ﹤0.01% |
+2,494
| New | +$50K |
|
787
Vanguard Real Estate ETF
VNQ
$34.4B
| $50K | ﹤0.01% |
615
| – | – |
|
|
PVLA
788
Palvella Therapeutics, Inc. Common Stock
PVLA
$661M
| $50K | ﹤0.01% |
110
-6
| -5% | -$2.73K |
|
|
OSG
789
DELISTED
Overseas Shipholding Group Inc.
OSG
| $50K | ﹤0.01% |
15,751
-648
| -4% | -$2.06K |
|
790
Interface
TILE
$1.6B
| $49K | ﹤0.01% |
2,112
-9
| -0.4% | -$209 |
|
|
NCI
791
DELISTED
Navigant Consulting, Inc.
NCI
| $49K | ﹤0.01% |
2,126
-10,089
| -83% | -$233K |
|
792
BioMarin Pharmaceuticals
BMRN
$10.5B
| $48K | ﹤0.01% |
490
| – | – |
|
|
DX
793
Dynex Capital
DX
$1.65B
| $47K | ﹤0.01% |
2,477
| – | – |
|
|
KG
794
Kestrel Group, Ltd.
KG
$199M
| $47K | ﹤0.01% |
828
+822
| +13,700% | +$46.7K |
|
795
PTC Therapeutics
PTCT
$4.63B
| $47K | ﹤0.01% |
979
-3,073
| -76% | -$148K |
|
|
SHYF
796
DELISTED
The Shyft Group
SHYF
| $47K | ﹤0.01% |
3,125
+417
| +15% | +$6.27K |
|
|
CUTR
797
DELISTED
Cutera, Inc.
CUTR
| $47K | ﹤0.01% |
1,420
+58
| +4% | +$1.92K |
|
798
Artisan Partners
APAM
$3.27B
| $46K | ﹤0.01% |
1,434
| – | – |
|
799
Catalyst Pharmaceutical
CPRX
$2.42B
| $46K | ﹤0.01% |
12,010
-4,502
| -27% | -$17.2K |
|
800
Equity Bancshares
EQBK
$809M
| $46K | ﹤0.01% |
1,180
+105
| +10% | +$4.09K |
|